Literature DB >> 14687935

Carboxypeptidase N: a pleiotropic regulator of inflammation.

Kirstin W Matthews1, Stacey L Mueller-Ortiz, Rick A Wetsel.   

Abstract

Carboxypeptidase N (CPN) is a plasma zinc metalloprotease, which consists of two enzymatically active small subunits (CPN1) and two large subunits (CPN2) that protect the protein from degradation. CPN cleaves carboxy-terminal arginines and lysines from peptides found in the bloodstream such as complement anaphylatoxins, kinins, and creatine kinase MM (CK-MM). By removing only one amino acid, CPN has the ability to change peptide activity and receptor binding. CPN is a member of a larger family of carboxypeptidases, many of which also cleave arginine and lysine. Because of the highly conserved active sites and the possible redundant functions of carboxypeptidases, it has been difficult to elucidate the role of CPN in disease processes. The future use of gene ablation technology may be the most appropriate way to understand the function of CPN in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687935     DOI: 10.1016/j.molimm.2003.10.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  57 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 2.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

3.  Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.

Authors:  Xianzhen Hu; Rick A Wetsel; Theresa N Ramos; Stacey L Mueller-Ortiz; Trenton R Schoeb; Scott R Barnum
Journal:  Immunobiology       Date:  2013-08-23       Impact factor: 3.144

4.  Diverse range of small peptides associated with high-density lipoprotein.

Authors:  Glen L Hortin; Rong-Fong Shen; Brian M Martin; Alan T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

Review 5.  The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 6.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

7.  Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation.

Authors:  David A Davis; Kathleen E Singer; Maria De La Luz Sierra; Masashi Narazaki; Fuquan Yang; Henry M Fales; Robert Yarchoan; Giovanna Tosato
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

8.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

Review 9.  Proteolytic regulatory mechanism of chemerin bioactivity.

Authors:  Xiao-Yan Du; Lawrence L K Leung
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-12       Impact factor: 3.848

10.  Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.

Authors:  Christian Drouet; Anik Désormeaux; Josée Robillard; Denise Ponard; Laurence Bouillet; Ludovic Martin; Gisèle Kanny; Denise-Anne Moneret-Vautrin; Jean-Luc Bosson; Jean-Louis Quesada; Margarita López-Trascasa; Albert Adam
Journal:  J Allergy Clin Immunol       Date:  2007-12-26       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.